299 related articles for article (PubMed ID: 7753821)
1. Glycosylation of the c-Myc transactivation domain.
Chou TY; Dang CV; Hart GW
Proc Natl Acad Sci U S A; 1995 May; 92(10):4417-21. PubMed ID: 7753821
[TBL] [Abstract][Full Text] [Related]
2. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas.
Chou TY; Hart GW; Dang CV
J Biol Chem; 1995 Aug; 270(32):18961-5. PubMed ID: 7642555
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.
Farina A; Faiola F; Martinez E
Protein Expr Purif; 2004 Apr; 34(2):215-22. PubMed ID: 15003254
[TBL] [Abstract][Full Text] [Related]
4. Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952.
Greis KD; Gibson W; Hart GW
J Virol; 1994 Dec; 68(12):8339-49. PubMed ID: 7966627
[TBL] [Abstract][Full Text] [Related]
5. O-linked N-acetylglucosamine and cancer: messages from the glycosylation of c-Myc.
Chou TY; Hart GW
Adv Exp Med Biol; 2001; 491():413-8. PubMed ID: 14533811
[TBL] [Abstract][Full Text] [Related]
6. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription.
Kamemura K; Hart GW
Prog Nucleic Acid Res Mol Biol; 2003; 73():107-36. PubMed ID: 12882516
[TBL] [Abstract][Full Text] [Related]
7. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
[TBL] [Abstract][Full Text] [Related]
8. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity.
Cheng X; Hart GW
J Biol Chem; 2001 Mar; 276(13):10570-5. PubMed ID: 11150304
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc glycosylated.
Lefebvre T; Pinte S; Guérardel C; Deltour S; Martin-Soudant N; Slomianny MC; Michalski JC; Leprince D
Eur J Biochem; 2004 Oct; 271(19):3843-54. PubMed ID: 15373830
[TBL] [Abstract][Full Text] [Related]
10. Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta.
Cheng X; Cole RN; Zaia J; Hart GW
Biochemistry; 2000 Sep; 39(38):11609-20. PubMed ID: 10995228
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the bHLH-zip domain of c-Myc with H1-type peptides. Characterization of helicity in the H1 peptides by NMR.
Draeger LJ; Mullen GP
J Biol Chem; 1994 Jan; 269(3):1785-93. PubMed ID: 8294427
[TBL] [Abstract][Full Text] [Related]
12. Steady-state localization of a medial-Golgi glycosyltransferase involves transit through the trans-Golgi network.
Opat AS; Houghton F; Gleeson PA
Biochem J; 2001 Aug; 358(Pt 1):33-40. PubMed ID: 11485549
[TBL] [Abstract][Full Text] [Related]
13. Mitotic arrest with nocodazole induces selective changes in the level of O-linked N-acetylglucosamine and accumulation of incompletely processed N-glycans on proteins from HT29 cells.
Haltiwanger RS; Philipsberg GA
J Biol Chem; 1997 Mar; 272(13):8752-8. PubMed ID: 9079710
[TBL] [Abstract][Full Text] [Related]
14. Localization of O-GlcNAc modification on the serum response transcription factor.
Reason AJ; Morris HR; Panico M; Marais R; Treisman RH; Haltiwanger RS; Hart GW; Kelly WG; Dell A
J Biol Chem; 1992 Aug; 267(24):16911-21. PubMed ID: 1512232
[TBL] [Abstract][Full Text] [Related]
15. Identification and origin of N-linked β-D-N-acetylglucosamine monosaccharide modifications on Arabidopsis proteins.
Kim YC; Jahren N; Stone MD; Udeshi ND; Markowski TW; Witthuhn BA; Shabanowitz J; Hunt DF; Olszewski NE
Plant Physiol; 2013 Jan; 161(1):455-64. PubMed ID: 23144189
[TBL] [Abstract][Full Text] [Related]
16. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAc and the control of gene expression.
Comer FI; Hart GW
Biochim Biophys Acta; 1999 Dec; 1473(1):161-71. PubMed ID: 10580136
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the oligosaccharide structures associated with the cystic fibrosis transmembrane conductance regulator.
O'Riordan CR; Lachapelle AL; Marshall J; Higgins EA; Cheng SH
Glycobiology; 2000 Nov; 10(11):1225-33. PubMed ID: 11087715
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
20. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.
Wells L; Vosseller K; Cole RN; Cronshaw JM; Matunis MJ; Hart GW
Mol Cell Proteomics; 2002 Oct; 1(10):791-804. PubMed ID: 12438562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
